Chelsea And Westminster Nhs Foundation Trust

This study observed 200 transgender and non-binary adults living with HIV across Europe over 18 months. Researchers collected health data and survey responses to understand how well HIV treatment works in this community and identify barriers to care. The goal is to gather informa…

This study aimed to understand why some people taking the HIV medication dolutegravir gain weight. Researchers gave the drug to 16 healthy, HIV-negative volunteers for 28 days to see if it changed how their bodies process sugar, fats, and hormones. The goal was to gather basic kn…